VYNE THERAPEUTICS INC. (YARW) Net margin 2016–2025
VYNE THERAPEUTICS INC. (YARW) net profit margin by fiscal year — reported net income divided by reported revenue.
-4646.1%FY2025 · since FY2016: -2087.2% → -4646.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4646.1% | +3304.8 pp |
| FY2024 | -7950.9% | -1240.5 pp |
| FY2023 | -6710.4% | -1844.5 pp |
| FY2022 | -4865.8% | +3010.5 pp |
| FY2021 | -7876.4% | -6659.0 pp |
| FY2020 | -1217.4% | +20267.5 pp |
| FY2019 | -21484.9% | -19421.9 pp |
| FY2018 | -2062.9% | -1428.4 pp |
| FY2017 | -634.6% | +1452.7 pp |
| FY2016 | -2087.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice